Mukti Sahoo
+91 70081 75918
mukti.sahoo@boehringer-ingelheim.com
At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. We work together globally and with integrity. Our focus articulates who we are and what we strive for, how we work and what we want to achieve. As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
In India, Boehringer Ingelheim is one the fastest growing multinational pharmaceutical. It was set up in 2003 and currently ranks 8th among MNCs. Boehringer Ingelheim India operates through its business areas of Human Pharmaceuticals, Animal Health and Clinical operations.
We have a strategic alliance with Lupin Ltd for diabetes in India. This partnership shows our commitment towards addressing challenges in diabetes management by providing broader access to innovative medicine. Through its research and scientific excellence, Boehringer Ingelheim India will continue to introduce innovative products to address the unmet medical needs.